News Archive for 2008

University of Virginia start-up company Tau Therapeutics LLC has been granted Food and Drug Administration orphan drug status for a pioneering treatment for pancreatic cancer.

Seven teams of University of Virginia inventors presented their research discoveries at Friday's 2008 Mid-Atlantic Innovation Showcase in McLean, Va.

Sometimes what makes a technology a "breakthrough" is the fact that it doesn't break through at all.

"When you think of metal, you probably think of a hunk of metal," says Cassandra L. Fraser, Ph.D.

When Bankole A. Johnson, M.D., Ph.D., D.Sc., first presented his ideas for a drug to cure alcoholism two decades ago — ideas that involved a major shift in the way scientists thought about the brain and its neurotransmitters — he was laughed right out of the lecture hall.

If current technology commercialization had a Holy Grail, it would probably be an effective alternative to gasoline.

It's frightening to think that only 15 years ago burn victims faced often insurmountable risks of infection, even in quality treatment facilities.

The University of Virginia Patent Foundation's annual report for fiscal year 2008 is now available online.

University of Virginia researchers Kevin R. Lynch, Ph.D., and Timothy L. Macdonald, Ph.D., have developed novel therapeutic compounds that could aid in the fight against cancer.

As the country faces what could be the worst financial crisis since the Great Depression, U.Va. Darden School of Business students launched a new student-run entrepreneurial society.

Burn victims suffer a unique agony. The pain of their injury is compounded by the rigorous cleansing required to ward off infection, a common and often fatal complication.

Local drug developer Adenosine Therapeutics was acquired Monday by Clinical Data, a global biotechnology company, in a deal that could be worth up to $66.2 million.

Medical Predictive Science Corporation (MPSC) announced that it will advance the HeRO™ system to market in Europe as a result of the European Patent Office giving notice of patent acceptance for technology used in the HeRO™ system.

The University of Virginia Patent Foundation honored the 2008 Edlich-Henderson Inventor of the Year and those University inventors who received U.S. patents and copyrights in 2007 at a special ceremony held Monday evening at the Boar's Head Inn.

A University of Virginia professor is being honored as the inventor of the year for a gel that treats burns and chronic wounds.

The University of Virginia Patent Foundation has selected George T. Rodeheaver, Ph.D., distinguished professor in U.Va.'s Department of Plastic Surgery, as the 2008 Edlich-Henderson Inventor of the Year.

The University of Virginia Patent Foundation has licensed innovative U.Va. silver nanoparticle technology to U.Va. start-up PluroGen Therapeutics Inc. for use as an enhanced anti-microbial agent to fight infection and promote wound-healing.

Technology developed at the University of Virginia could soon have a dramatic impact on male contraception practices throughout the U.S.